Viewing Study NCT00616005

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-02-27 @ 8:28 AM
Study NCT ID: NCT00616005
Status: COMPLETED
Last Update Posted: 2014-08-18
First Post: 2008-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
Sponsor: Duke University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glioblastoma View
None GBM View
None Brain tumor View
None Temodar View
None Temozolomide View
None Irinotecan View
None CPT-11 View
None Camptosar View
None Malignant glioma View
None Anaplastic astrocytoma View
None Glioblastoma multiforme View